Добавлено 28.09.2020, 10:20:04 в HealthCare Research Reports | Категория Здоровье

The Drug Repurposing Service Providers Market is estimated to be worth USD 1.2 billion in 2030, predicts Roots Analysis Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs